Developer docs
API playgroundTry for free, no card

Search company profiles

Wavemaker 360

Full company profile

uuid0000f65

Namestring
Wavemaker 360
Legal namestring
Wavemaker Three-Sixty Health
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Wavemaker Three-Sixty Health, operating as Wavemaker 360, is a US-based venture capital fund founded in 2017 and headquartered in Pasadena, California, with secondary offices in New York and a sister fund in Singapore (Wavemaker Pacific). The firm invests exclusively in early-stage (seed and Series A follow-on) healthcare companies across health-tech, digital health, medical devices, pharma-tech, telehealth, healthcare marketplaces, and science-driven categories, explicitly excluding bio-pharma drug discovery. Wavemaker 360 writes first checks of $500K-$2MM and reserves 2X-4X for follow-on at Series A/B, always co-investing alongside other VCs, hospitals, and corporates in $2MM-$8MM financings. Investment allocation skews roughly 25% Southern California, 25% Northern California, and 50% rest of US and select international markets including Canada, Western Europe, and Asia (with US market entry as a requirement). The fund is guided by a proprietary 'Quintuple Aim' framework spanning patient experience, cost reduction, provider revenue, clinician experience, and clinical outcomes.

The fund's defining differentiator is its 300+ Limited Partner base, the majority of whom are healthcare industry veterans from 200+ institutions including Cleveland Clinic, Cedars-Sinai, HCA Healthcare, UCLA Health, UCSF Health, Kaiser Permanente, UnitedHealth Group, Stanford Medicine, Vanderbilt University Medical Center, Boston Scientific, and Danaher. These LPs are organized into a 'Portfolio Support Alliance' that drives deal sourcing, diligence, and commercial introductions for portfolio companies, supported by a 'Surf Camp' deep-dive event cadence every 2-3 months. The core team of General Partners (John Nackel, Jay Goss), Partner Maxim Owen, CFO Lisa Riedmiller, and Venture Partner/Head of AI Matt Michelson manages three funds with approximately $200MM AUM, 60 portfolio companies, and aggregate portfolio value exceeding $1.5-2.5BB. Recent investments include Citizen Health, Iterative Health, Carlsmed, Tombot, ChemT Biotechnology, Lium, and 01Health. Revenue is generated through standard 2% management fees on committed capital and 20% carried interest on fund returns above the hurdle rate.

Short descriptiontext

Wavemaker 360 is a US-based healthcare-exclusive seed and Series A venture capital fund managing ~$200MM across three funds, with 60 portfolio companies and a 300+ Limited Partner base of healthcare industry operators providing deal sourcing and commercial support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPasadena, United States
HQ citystring
Pasadena
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
seed-stage venture capital, healthcare investment fund, early-stage healthcare, digital health investing, venture capital management
Industry1 code
PRIMARYFSANAHAH
Corporate LP Programs (Corporate as LP in VC/PE funds)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code2 codes
  • Investment Advice6282
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Venture Capital / Healthcare Investment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Standard VC management fees charged on committed capital to cover fund operations and deal sourcing activities.

wavemaker360.com
2Carried Interest (Carry)
TypeTransaction Fee
Description

Performance fee from successful portfolio company exits, typically 20% of profits above the hurdle rate, which is the primary economic driver for VC fund managers.

wavemaker360.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Three-Sixty Advisory Group
Description

Boutique healthcare consultancy that effectively founded Wavemaker Three-Sixty in 2017

wavemaker360.com
+4 more records
Core offering1 text field

Wavemaker 360 is a US healthcare-exclusive seed-stage venture capital fund that invests in healthcare disruptors across health-tech, digital health, medical devices, pharma-tech, telehealth, and healthcare marketplaces. The fund writes first checks of $500K-$2MM with reserves of 2X-4X for follow-on Series A/B rounds, and supplements capital with commercial support drawn from a network of 300+ healthcare industry Limited Partners. Portfolio companies also gain access to recurring "Surf Camp" deep-dive events and a Portfolio Support Alliance of curated healthcare-experienced LPs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 60 companies in 3 funds with aggregate portfolio value exceeding $2.5BB
+2 more records
Product overview1 text field

Wavemaker Three-Sixty Health is a healthcare-focused venture capital firm that invests in healthcare disruptors including health-tech, digital health, medical devices, pharma-tech, telehealth, and healthcare marketplace companies. The firm operates three funds managing approximately $1.5BB in portfolio company value across 60 companies in the US, Canada, and Southeast Asia. The firm typically writes seed-stage checks of $500K-$2MM with reserves for 2X-4X follow-on investments into Series A/B rounds. The firm's investment thesis centers on the Quintuple Aim of Healthcare: improved patient experience, lower costs, new revenue streams for providers, improved outcomes for clinicians, and better clinical outcomes.

Product and service1 record
1Seed-Stage Healthcare Venture Capital Funds
CategoryVenture Capital Fund
Description

Pooled venture capital funds (three funds to date) that invest $500K-$2MM first checks into US seed-stage healthcare startups with reserves of 2X-4X for Series A/B follow-on. LPs commit capital under standard VC fund economics (approximately 2% management fee, 20% carried interest).

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boutique healthcare consultancy that effectively founded Wavemaker Three-Sixty in 2017. While there is occasional synergy between the consultancy and the fund, the two companies run autonomously.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wavemaker has a 'sister fund' headquartered in Singapore for Southeast Asia investments. The fund considers Western Europe and Asia investments provided startups have near-term plans to expand into the US.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

One of many healthcare institution relationships through LPs or formalized partnerships providing deal flow, industry insights, and potential commercial partnerships.

4Cedars-Sinai Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare institution LP relationship providing deal flow and commercial support network for portfolio companies.

wavemaker360.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare institution relationship through LP network for deal sourcing and potential portfolio company support.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Regulatory relationship providing industry insights and potential guidance for portfolio companies navigating regulatory pathways.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Large hospital system relationship providing deal flow and commercial network access for portfolio companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Integrated healthcare system relationship for deal sourcing and potential commercial partnerships.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic medical center relationship for deal flow and clinical/commercial insights.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic medical center relationship providing deal flow and clinical network access.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic medical center relationship for deal sourcing and potential portfolio support.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Major payer relationship providing industry insights and potential commercial pathways for portfolio companies.

13Vanderbilt University Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic medical center relationship through LP network for deal flow and commercial support.

wavemaker360.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Medical device company LP relationship providing industry expertise and potential commercial pathways.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare conglomerate LP relationship for industry insights and potential portfolio company support.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Formal and informal relationships with hospitals, health systems, academic medical centers, medical schools, post-acute care, urgent care including: City of Hope, Houston Methodist, Scripps Health, Sentara Healthcare, Texas Health Resources, Trinity Health, Pennant Group, Envision Healthcare, and many more.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused early-stage venture fund investing in health transformers; directly comparable model. Anne Dordai, Wavemaker 360's Head of Portfolio and Platform, was previously at StartUp Health.

TypeDirect peer
Description

Early-stage venture capital firm focused exclusively on healthcare technology and services, with similar check sizes and LP-driven value-add model.

TypeDirect peer
Description

Digital health-focused growth equity firm that co-led Citizen Health's $14.5MM seed alongside Wavemaker 360, operating with comparable healthcare-focused thesis.

TypeDirect peer
Description

Early-stage venture capital firm investing in digital health and tech-enabled healthcare services with a focus on commercial-stage companies, closely overlapping Wavemaker 360's health-tech thesis.

TypeDirect peer
Description

Early-stage venture capital firm investing in healthcare and technology companies with similar check sizes and value-add LP network model.

TypeDirect peer
Description

Healthcare-focused early-stage investor backing data, analytics, and digital health companies — directly comparable vertical focus and stage.

TypeBroad incumbent
Description

Large multi-stage venture firm with a dedicated bio/health fund investing across healthcare stages; broader portfolio and larger check sizes make it an incumbent competitor for top healthcare deals.

TypeBroad incumbent
Description

Large multi-stage venture firm with a Health Assurance-focused practice that competes for healthcare founders across all stages, including seed.

TypeBroad incumbent
Description

Strategic corporate venture arm of UnitedHealth/Optum investing broadly in healthcare innovation; provides much larger check sizes and strategic distribution that competing funds must contend with.

TypeEmerging player
Description

Early-stage venture firm investing in science and technology-driven startups, including healthcare and life sciences; overlaps at the seed stage but with a broader cross-sector mandate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment97 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wavemaker 360

Venture Capital / Healthcare Investmentwavemaker360.com

Wavemaker 360 is a US-based healthcare-exclusive seed and Series A venture capital fund managing ~$200MM across three funds, with 60 portfolio companies and a 300+ Limited Partner base of healthcare industry operators providing deal sourcing and commercial support.

What Wavemaker 360 does

Wavemaker Three-Sixty Health, operating as Wavemaker 360, is a US-based venture capital fund founded in 2017 and headquartered in Pasadena, California, with secondary offices in New York and a sister fund in Singapore (Wavemaker Pacific). The firm invests exclusively in early-stage (seed and Series A follow-on) healthcare companies across health-tech, digital health, medical devices, pharma-tech, telehealth, healthcare marketplaces, and science-driven categories, explicitly excluding bio-pharma drug discovery. Wavemaker 360 writes first checks of $500K-$2MM and reserves 2X-4X for follow-on at Series A/B, always co-investing alongside other VCs, hospitals, and corporates in $2MM-$8MM financings. Investment allocation skews roughly 25% Southern California, 25% Northern California, and 50% rest of US and select international markets including Canada, Western Europe, and Asia (with US market entry as a requirement). The fund is guided by a proprietary 'Quintuple Aim' framework spanning patient experience, cost reduction, provider revenue, clinician experience, and clinical outcomes.

The fund's defining differentiator is its 300+ Limited Partner base, the majority of whom are healthcare industry veterans from 200+ institutions including Cleveland Clinic, Cedars-Sinai, HCA Healthcare, UCLA Health, UCSF Health, Kaiser Permanente, UnitedHealth Group, Stanford Medicine, Vanderbilt University Medical Center, Boston Scientific, and Danaher. These LPs are organized into a 'Portfolio Support Alliance' that drives deal sourcing, diligence, and commercial introductions for portfolio companies, supported by a 'Surf Camp' deep-dive event cadence every 2-3 months. The core team of General Partners (John Nackel, Jay Goss), Partner Maxim Owen, CFO Lisa Riedmiller, and Venture Partner/Head of AI Matt Michelson manages three funds with approximately $200MM AUM, 60 portfolio companies, and aggregate portfolio value exceeding $1.5-2.5BB. Recent investments include Citizen Health, Iterative Health, Carlsmed, Tombot, ChemT Biotechnology, Lium, and 01Health. Revenue is generated through standard 2% management fees on committed capital and 20% carried interest on fund returns above the hurdle rate.

Wavemaker 360 firmographics

Firmographics
Name
Wavemaker 360
Legal name
Wavemaker Three-Sixty Health
Website
https://wavemaker360.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Wavemaker 360 is a US-based healthcare-exclusive seed and Series A venture capital fund managing ~$200MM across three funds, with 60 portfolio companies and a 300+ Limited Partner base of healthcare industry operators providing deal sourcing and commercial support.
Ownership category
akta.pro rank

Wavemaker 360 industry classification

Industry
Product category
Venture Capital / Healthcare Investment
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSANAHAH
Corporate LP Programs (Corporate as LP in VC/PE funds)

Keywords

  • Seed-stage venture capital
  • Healthcare investment fund
  • Early-stage healthcare
  • Digital health investing
  • Venture capital management

Where Wavemaker 360 is headquartered

Location

Headquarters

HQ city
Pasadena
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Wavemaker 360 business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Management Fees: Standard VC management fees charged on committed capital to cover fund operations and deal sourcing activities.
  2. Carried Interest (Carry): Performance fee from successful portfolio company exits, typically 20% of profits above the hurdle rate, which is the primary economic driver for VC fund managers.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Wavemaker 360 product offering

Product offering

Core offering

Wavemaker 360 is a US healthcare-exclusive seed-stage venture capital fund that invests in healthcare disruptors across health-tech, digital health, medical devices, pharma-tech, telehealth, and healthcare marketplaces. The fund writes first checks of $500K-$2MM with reserves of 2X-4X for follow-on Series A/B rounds, and supplements capital with commercial support drawn from a network of 300+ healthcare industry Limited Partners. Portfolio companies also gain access to recurring "Surf Camp" deep-dive events and a Portfolio Support Alliance of curated healthcare-experienced LPs.

Product overview

Wavemaker Three-Sixty Health is a healthcare-focused venture capital firm that invests in healthcare disruptors including health-tech, digital health, medical devices, pharma-tech, telehealth, and healthcare marketplace companies. The firm operates three funds managing approximately $1.5BB in portfolio company value across 60 companies in the US, Canada, and Southeast Asia. The firm typically writes seed-stage checks of $500K-$2MM with reserves for 2X-4X follow-on investments into Series A/B rounds. The firm's investment thesis centers on the Quintuple Aim of Healthcare: improved patient experience, lower costs, new revenue streams for providers, improved outcomes for clinicians, and better clinical outcomes.

Differentiator

Problem solved

Functional benefit

Brands

  • Three-Sixty Advisory Group: Boutique healthcare consultancy that effectively founded Wavemaker Three-Sixty in 2017
  • Surf Break
  • Surf Camp
  • Start-Up Gateway
  • Portfolio Support Alliance

Products and services

  • Seed-Stage Healthcare Venture Capital Funds Pooled venture capital funds (three funds to date) that invest $500K-$2MM first checks into US seed-stage healthcare startups with reserves of 2X-4X for Series A/B follow-on. LPs commit capital under standard VC fund economics (approximately 2% management fee, 20% carried interest).

Quantifiable outcome

  • 60 companies in 3 funds with aggregate portfolio value exceeding $2.5BB
  • +2 more outcomes

Companies that use Wavemaker 360

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Wavemaker 360 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Wavemaker 360 partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and minor.

  • Three-Sixty Advisory GroupcoreStrategic or Co-development PartnerBoutique healthcare consultancy that effectively founded Wavemaker Three-Sixty in 2017. While there is occasional synergy between the consultancy and the fund, the two companies run autonomously.
  • Wavemaker (Singapore Sister Fund)coreStrategic or Co-development PartnerWavemaker has a 'sister fund' headquartered in Singapore for Southeast Asia investments. The fund considers Western Europe and Asia investments provided startups have near-term plans to expand into the US.
  • Atrium HealthminorStrategic or Co-development PartnerOne of many healthcare institution relationships through LPs or formalized partnerships providing deal flow, industry insights, and potential commercial partnerships.
  • Cedars-Sinai Medical CenterminorStrategic or Co-development PartnerHealthcare institution LP relationship providing deal flow and commercial support network for portfolio companies.
  • Cleveland ClinicminorStrategic or Co-development PartnerHealthcare institution relationship through LP network for deal sourcing and potential portfolio company support.
  • FDAminorStrategic or Co-development PartnerRegulatory relationship providing industry insights and potential guidance for portfolio companies navigating regulatory pathways.
  • HCA HealthcareminorStrategic or Co-development PartnerLarge hospital system relationship providing deal flow and commercial network access for portfolio companies.
  • Kaiser PermanenteminorStrategic or Co-development PartnerIntegrated healthcare system relationship for deal sourcing and potential commercial partnerships.
  • Stanford MedicineminorStrategic or Co-development PartnerAcademic medical center relationship for deal flow and clinical/commercial insights.
  • UCLA HealthminorStrategic or Co-development PartnerAcademic medical center relationship providing deal flow and clinical network access.
  • UCSF HealthminorStrategic or Co-development PartnerAcademic medical center relationship for deal sourcing and potential portfolio support.
  • UnitedHealth GroupminorStrategic or Co-development PartnerMajor payer relationship providing industry insights and potential commercial pathways for portfolio companies.
  • Vanderbilt University Medical CenterminorStrategic or Co-development PartnerAcademic medical center relationship through LP network for deal flow and commercial support.
  • Boston ScientificminorStrategic or Co-development PartnerMedical device company LP relationship providing industry expertise and potential commercial pathways.
  • Danaher CorporationminorStrategic or Co-development PartnerHealthcare conglomerate LP relationship for industry insights and potential portfolio company support.
  • 200+ Healthcare Institutions (Partial List)minorStrategic or Co-development PartnerFormal and informal relationships with hospitals, health systems, academic medical centers, medical schools, post-acute care, urgent care including: City of Hope, Houston Methodist, Scripps Health, Sentara Healthcare, Texas Health Resources, Trinity Health, Pennant Group, Envision Healthcare, and many more.

Scale indicators7 records

Recent moves3 records

Expansion highlights5 records

Wavemaker 360 competitors and assessment

Company assessment

Direct peers

  • StartUp Health: Healthcare-focused early-stage venture fund investing in health transformers; directly comparable model. Anne Dordai, Wavemaker 360's Head of Portfolio and Platform, was previously at StartUp Health.
  • Flare Capital Partners: Early-stage venture capital firm focused exclusively on healthcare technology and services, with similar check sizes and LP-driven value-add model.
  • Transformation Capital: Digital health-focused growth equity firm that co-led Citizen Health's $14.5MM seed alongside Wavemaker 360, operating with comparable healthcare-focused thesis.
  • Define Ventures: Early-stage venture capital firm investing in digital health and tech-enabled healthcare services with a focus on commercial-stage companies, closely overlapping Wavemaker 360's health-tech thesis.
  • .406 Ventures: Early-stage venture capital firm investing in healthcare and technology companies with similar check sizes and value-add LP network model.
  • Health Catalyst Capital: Healthcare-focused early-stage investor backing data, analytics, and digital health companies — directly comparable vertical focus and stage.

Broad incumbents

  • Andreessen Horowitz (a16z Bio/Health): Large multi-stage venture firm with a dedicated bio/health fund investing across healthcare stages; broader portfolio and larger check sizes make it an incumbent competitor for top healthcare deals.
  • General Catalyst: Large multi-stage venture firm with a Health Assurance-focused practice that competes for healthcare founders across all stages, including seed.
  • Optum Ventures: Strategic corporate venture arm of UnitedHealth/Optum investing broadly in healthcare innovation; provides much larger check sizes and strategic distribution that competing funds must contend with.

Emerging players

  • Lux Capital: Early-stage venture firm investing in science and technology-driven startups, including healthcare and life sciences; overlaps at the seed stage but with a broader cross-sector mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Wavemaker 360 social profiles

Digital presence

Wavemaker 360 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wavemaker 360 leadership team

Management profile

Number of profiles

Profiles14 records

Wavemaker 360 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wavemaker 360 M&A and investment

M&A and investment

M&A

Investments97 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wavemaker 360

What does Wavemaker 360 do?

Wavemaker 360 is a US healthcare-exclusive seed-stage venture capital fund that invests in healthcare disruptors across health-tech, digital health, medical devices, pharma-tech, telehealth, and healthcare marketplaces. The fund writes first checks of $500K-$2MM with reserves of 2X-4X for follow-on Series A/B rounds, and supplements capital with commercial support drawn from a network of 300+ healthcare industry Limited Partners. Portfolio companies also gain access to recurring "Surf Camp" deep-dive events and a Portfolio Support Alliance of curated healthcare-experienced LPs.

Is Wavemaker 360 a public or private company?

Wavemaker 360 is a private company. It is classified as management employee owned and is currently operating.

When was Wavemaker 360 founded?

Wavemaker 360 was founded in 2017. It employs 11 to 50 people.

Where is Wavemaker 360 based?

Wavemaker 360 is headquartered in Pasadena, United States, in the North America region.

How does Wavemaker 360 make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest (Carry).

Who are Wavemaker 360's main competitors?

Direct peers on record are StartUp Health, Flare Capital Partners, Transformation Capital, Define Ventures, .406 Ventures and Health Catalyst Capital. Broad incumbents are Andreessen Horowitz (a16z Bio/Health), General Catalyst and Optum Ventures. Lux Capital is listed as an emerging player.

Does Wavemaker 360 have an API?

No public API is recorded for Wavemaker 360.

What industry is Wavemaker 360 in?

Wavemaker 360's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAHAH, Corporate LP Programs (Corporate as LP in VC/PE funds). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LA Business JournalTombot Lands New Funding Round - Inside The ValleyTombot Inc., a Santa Clarita-based robotics company, raised $7 million in a funding round in late June to scale manufacturing and commercialize its lifelike robotic companion dog, Jennie, targeting elderly patients with cognitive decline. The round, which exceeds the company's previous $6.1 million funding last year, was co-led by Wavemaker 360, Caduceus Capital Partners, Florida Community Health Network, and Lutheran Foundation for Long Term Living, with over 23,000 customers on the preorder and waitlist roster. The article highlights a growing market opportunity driven by aging Baby Boomer populations, caregiver shortages, and increasing loneliness among elderly patients requiring cognitive support.Venture Capital Access OnlineMaterna Announces Successful $5 Million B3 Financing to Support Transformational Year AheadMaterna Medical closed a $5 million B3 financing round led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels. The funding will support the EASE pivotal trial readout, expand Milli channel access, and prepare for the Ellora Obstetrical System launch, with its first-in-class reimbursement code now active.YahooMaterna Announces Successful $5 Million B3 Financing to Support Transformational Year AheadMaterna Medical closed a $5 million B3 financing round led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels. The funding will support the EASE trial readout, expand Milli channel access, and prepare for the Ellora Obstetrical System launch, with its first-in-class reimbursement code now active.FinSMEsMaterna Medical Raises $5M in B3 FinancingMaterna Medical closed a $5M B3 financing round led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels. The funds will complete the EASE pivotal trial readout, expand Milli channel access, and prepare for the Ellora Obstetrical System launch. The company's first-in-class reimbursement code is now active.Venture Capital Access OnlineTombot Closes $7 Million Series A3 Growth Financing to Scale Operations and Expand Companion Robotics Product LineTombot closed a $7 million Series A3 financing round led by Caduceus Capital Partners, with participation from Wavemaker 360, the Lutheran Foundation, and Florida Community Health Network. The company has secured over 23,000 pre-order and waitlist customers for its flagship robotic companion Jennie, ahead of a planned Fall 2026 customer launch.TNGlobalSingapore's ChemT Biotechnology raises $4M seed round to build AI intelligence layer for biomanufacturingChemT Biotechnology closed a $4 million seed round led by Wavemaker Ventures and SEEDS. The funding supports its CelMo AI platform for biomanufacturing, which simulates cell behavior, and expansion into stem cells and other cell types.FinSMEsChemT Biotechnology Raises $4M in Seed FundingChemT Biotechnology, a Singapore-based AI-driven biotech, raised $4M in seed funding led by Wavemaker Ventures. The round brings total funding to $5M after $1M in angel investment. Funds will support AI infrastructure, advancing products toward GMP standards, and scaling commercial partnerships.The SaaS NewsLium Raises $5.5M SeedLium, a Dallas-based software company, announced it raised $5.5 million in seed funding from SJF Ventures, Wavemaker 360, Reach Capital, and GC&H Investments to commercialize its AI platform. The platform enables organizations in energy, geospatial analytics, space, engineering, and manufacturing sectors to interact with complex datasets such as seismic surveys and satellite imagery using natural language. Founded in 2024 by Josh Knutson, Ryan Thill, and Ward Vuillemot, Lium aims to help organizations process fragmented data into structures that AI systems can reliably analyze.FinSMEs01Health Raises €12.9M in Series A Funding01Health, a London-based decentralized healthcare platform, raised €12.9M in Series A funding led by Gresham House Ventures. The company will use the funds to scale its platform in the UK, expand into the US, and accelerate pilot trials in North American medical networks.Pulse 2.0Lium Raises $5.5 Million Seed Funding And Launches AI Platform For Complex Scientific And Industrial DataLium (formerly Astromind), a Dallas-based company founded in 2024, has emerged from stealth and launched an AI platform that makes complex scientific and industrial datasets accessible through natural language, while disclosing $5.5 million in seed funding from SJF Ventures, Wavemaker 360, Reach Capital, and GC&H Investments. The platform, initially developed through astrophysics work with NASA's Chandra X-ray Observatory, targets industries including energy, geospatial analytics, space, engineering, manufacturing, and scientific research, and is already being used by nexGEN for generator health reporting, by Imaged Reality integrated into its Stratbox platform for geological analysis, and by the North Carolina Institute for Climate Studies for processing NOAA weather and climate data.